Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

A needle in the 'cancer vaccine' haystack

Nature Medicine volume 16, pages 854–856 (2010)Cite this article

Subjects

Vaccines can prevent infections by several pathogens. Success, however, has been limited for other chronic diseases, reflecting a constraint for effectively manipulating the human immune system. The results from four studies describe a novel dendritic cell (DC) subset in humans that may be crucial for the design of vaccines against cancer and other chronic diseases.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Alternative antitumor vaccine strategies based on a previously undescribed BDCA3-expressing DC subset.

Katie Vicari

References

  1. Sabado, R.L. & Bhardwaj, N. Immunotherapy 2, 37–56 (2010).

    Article  CAS  Google Scholar 

  2. Steinman, R.M. & Banchereau, J. Nature 449, 419–426 (2007).

    Article  CAS  Google Scholar 

  3. Shortman, K. & Heath, W.R. Immunol. Rev. 234, 18–31 (2010).

    Article  CAS  Google Scholar 

  4. Bachem, A. et al. J. Exp. Med. 207, 1273–1281 (2010).

    Article  CAS  Google Scholar 

  5. Crozat, K. et al. J. Exp. Med. 207, 1283–1292 (2010).

    Article  CAS  Google Scholar 

  6. Jongbloed, S.L. et al. J. Exp. Med. 207, 1247–1260 (2010).

    Article  CAS  Google Scholar 

  7. Poulin, L.F. et al. J. Exp. Med. 207, 1261–1271 (2010).

    Article  CAS  Google Scholar 

  8. Sancho, D. et al. J. Clin. Invest. 118, 2098–2110 (2008).

    Article  CAS  Google Scholar 

  9. Sancho, D. et al. Nature 458, 899–903 (2009).

    Article  CAS  Google Scholar 

  10. Dorner, B.G. et al. Immunity 31, 823–833 (2009).

    Article  CAS  Google Scholar 

  11. Schulz, O. et al. Nature 433, 887–892 (2005).

    Article  CAS  Google Scholar 

  12. Higano, C.S. et al. Nat. Rev. Drug. Discov. 9, 513–514 (2010).

    Article  CAS  Google Scholar 

  13. Dubsky, P. et al. Eur. J. Immunol. 37, 1678–1690 (2007).

    Article  CAS  Google Scholar 

  14. Mailliard, R.B. et al. Cancer Res. 64, 5934–5937 (2004).

    Article  CAS  Google Scholar 

  15. Minkis, K. et al. Cancer Res. 68, 9441–9450 (2008).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Anne Gallois and Nina Bhardwaj are at the New York University School of Medicine, New York University Langone Medical Center, Cancer Institute, New York, New York, USA.,

    Anne Gallois & Nina Bhardwaj

Authors
  1. Anne Gallois
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nina Bhardwaj
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Anne Gallois or Nina Bhardwaj.

Ethics declarations

Competing interests

The authors declare competing financial interests: details accompany the full-text HTML version of the paper at http://www.nature.com/naturemedicine/.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gallois, A., Bhardwaj, N. A needle in the 'cancer vaccine' haystack. Nat Med 16, 854–856 (2010). https://doi.org/10.1038/nm0810-854

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm0810-854

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer